SCHEMBL10212867

SCHEMBL10212867

Cc1noc(-c2ccccc2)c1CN1CCC[C@@H](F)C1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
SLC6A9 P48067 1/20 0.40
S1PR1 P21453 4/20 0.38
S1PR3 Q99500 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 2/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.37
CNR2 P34972 1/20 0.37
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15084374 0.87 HRH3 (0.45) HCRTR1HCRTR2SLC6A9ALDH1A1MAPT
SCHEMBL15081973 0.84 HCRTR1 (0.39) HCRTR1HCRTR2SLC6A9S1PR1S1PR3
SCHEMBL10210895 0.82 ALDH1A1 (0.47) HCRTR1HCRTR2SLC6A9ALDH1A1MAPT
SCHEMBL3552 0.79 DRD2 (0.44) ALDH1A1MAPTSMN1; SMN2CYP2D6CNR2
Bicarbonate SCHEMBL18167233 0.79 DRD2 (0.42) SLC6A9S1PR1S1PR3ALDH1A1CNR2
SCHEMBL4223 0.74 CYP1A2 (0.42) HCRTR1HCRTR2ALDH1A1MAPTSMN1; SMN2
Bicarbonate SCHEMBL18167182 0.74 ACKR3 (0.44) S1PR1ALDH1A1SMN1; SMN2CYP2D6KDM4E
SCHEMBL807393 0.73 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2CYP2D6CNR2L3MBTL1
SCHEMBL5236 0.72 OPRM1 (0.43) ATML3MBTL1
SCHEMBL11226 0.71 DRD2 (0.37) HCRTR1HCRTR2SLC6A9S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036997-A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS SCHERING CORPORATION (US) 2012-03-22 WO disclosed